📌 Key Takeaways
- Topic: Fused Silica Powder Supplier: Purity, Particle Size Options and Selection Tips
- Keywords: matting agent for coatings
- Published: 2026-11-20 13:45:40
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Tridymite? Structure, Formation and Properties of This Silica Polymorph
- Silica 99% Purity: Specifications, Grades and Typical Applications
- Silica Exposure Limits: OSHA, ACGIH and EU Limits Compared
- The immune activation through functional nanocarriers is realized by interactions with innate immune cells such as macrophages, neutrophils, and complement proteins. Immune recognition triggers inflammation, immune responses, or even swift clearance, thus presumably constraining therapeutic effects. Surface properties, such as chemical composition, topography, and charge, may influence the immune cell activation and binding specificity. The possible immune interactions need to be well characterized for the development of stealth and immunocompatible nanoparticles [ 82 ]. Immune-derived side influences, such as cytokine release and complement activation, potentially corrupt the safety and the effectiveness of drug delivery [ 80 ]. Other problems that may affect nanoparticle penetration and the effectiveness of targeting are the heterogeneity of the target tissue and tumor microenvironment. Problems of stability, biodegradation rates, and nanoparticle agglomeration may also affect the effectiveness of action [ 80 ].
- Mica Powder vs Silica: Properties and Applications Compared
- 90. Li X., Xue M., Raabe O.G., Aaron H.L., Eisen E.A., Evans J.E., Hayes F.A., Inaga S., Tagmount A., Takeuchi M., et al. Aerosol droplet delivery of mesoporous silica nanoparticles: A plan for respiratory-based therapeutics. Nanomedicine. 2015;11:1377-1385. doi: 10.1016/j.nano.2015.03.007. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Silica Supplier Middle East: Sourcing Options, Logistics and Key Markets
- 7.1.1. Low-Dose Tablets
Silica Industry Outlook 2026: Challenges, Opportunities and Growth Areas
What is silica (SiO₂)?
fumed silica 53. Kramarczyk D., Knapik-Kowalczuk J., Smolka W., Monteiro M.F., Tajber L., Paluch M. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin. Eur. J. Pharm. Sci. 2022;171:106132. doi: 10.1016/j.ejps.2022.106132. [ DOI ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
58. Kinnari P., Mäkilä E., Heikkilä T., Salonen J., Hirvonen J., Santos H.A. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharm. 2011;414:148-156. doi: 10.1016/j.ijpharm.2011.05.021. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
silica for tires One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.